Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Multiple myeloma
BCMA and GPRC5D CAR-T cells and bispecifics, and what is left after triple-class exposure.
SITC Annual Meeting 2026
4–8 Nov 2026, Phoenix · Journal for ImmunoTherapy of Cancer 14 (Suppl 2 and 3), open access
1,109 regular and 19 late-breaking abstracts are in Crossref as open-access JITC supplement records (CC BY-NC); the supplement may still be filling in.
Indexed in Crossref
9 abstracts matching multiple myeloma from the meeting's journal supplement, fetched live from Crossref 2026-11-12 11:05 UTC. This is a keyword search, not the complete abstract book.
- 585Anti-CD38 based regimens provide significant survival benefits and deeper responses in frail patients with multiple myeloma. A systematic reviewAlicia M N Batista, Aymane Bennani, Venkata Peesapati, Augusto Gaidukas et al.
- 251Product characterization of a clinical-grade BCMA CAR-MIL therapy supports IND-enabling development for multiple myelomaSeung joo Yang, Yu-Jin Park, Bomi Park, Manh-Cuong Vo et al.
- 485Metabolomic and lipidomic analyses reveal early biomarkers linked to treatment response to BCMA-TCE in patients with relapsed/refractory multiple myelomaEthan G Thompson, Ethan Stancliffe, Monil Gandhi, Nathan Martin et al.
- 402Leveraging a high-fiber diet to intercept smoldering multiple myeloma progression and enhance early immunotherapy efficacyAnna Policastro, Laura Lucia Cogrossi, Matteo Grioni, Camilla Marchigiani et al.
- 613Survival trends and clinical outcomes in multiple myeloma following BCMA-directed immunotherapy: a propensity score–matched real-world comparison of CAR-T cell therapy versus teclistamabDamilola Ologbe, Olanipekun Lanny Ntukidem, Jeffrey Afrifa-Yamoah, Oboseh John Ogedegbe et al.
- 209Novel BCMA/GPRC5D dual-targeting CAR-T cells mitigate antigen escape with a favorable safety profile for multiple myelomaKun Luo, Peirong Hu, Xu Wang, Michael Wagner et al.
- 243GT860, a T-Cell-targeted lentiviral in vivo dual BCMA/GPRC5D CAR-T candidate, demonstrates early clinical activity and safety in multiple myelomaJingwei Sun, Jiahui Jin, Jingman Wang, Yiyang Tan et al.
- 148Spatial transcriptomics and proteomics determinants of resistance to T cell engagers in extramedullary multiple myelomaHyo Jeong Nam, Darwin D’Souza, Raina Roche, Emir Radkevich et al.
- 1185IDP-023 allogeneic g-NK cells combined with isatuximab in relapse/refractory multiple myeloma: complete safety, efficacy, and tumor microenvironment remodeling from a Phase 1/2 first-in-human studyKrina Patel, David Berz, Mitul Gandhi, Krish Patel et al.